PRIME THERAPEUTICS for PRIME THERAPEUTICS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Law Enforcement/Crime/Criminal Justice LAW
S.480/H.R.1725, "National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015," educating on the importance of PDMPs and the need for federal funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG New | — |
Pharmacy PHA
S.524, Comprehensive Addiction and Recovery Act, focused on Prescription Drug Management Plans (PDMPs). H.R.4784, Lower Drug Costs Through Competition Act, support increasing generic availability. S.2680, A bill to amend the Public Health Service Act to provide comprehensive mental health reform, and for other purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG New | — |
Medicare/Medicaid MMM
S.524 "Comprehensive Addiction and Recovery Act," focused on Prescription Drug Management Plans (PDMPs). H.R.244, "MAC Transparency Act," educating on how MAC pricing helps control costs for consumers. H.R.793/S.1190, "Ensuring Seniors Access to Local Pharmacies Act of 2015," importance of pharmacy networks in reducing costs. H.R.1600, "The Patients' Access to Treatment Act," educating on the importance of step therapy to ensuring optimal therapy access and cost control. S.480/H.R.1725, "National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015," educating on the importance of PDMPs and the need for federal funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG New | — |
Health Issues HCR
S.524, "Comprehensive Addiction and Recovery Act," focused on Prescription Drug Management Plans (PDMPs). S.1945, Senate HELP mental health reform package, "Mental Health Reform Act of 2016," mental health parity treatment of step therapy and prior-authorization. S.2615, "Increasing Competition in Pharmaceuticals Act," support increasing generic availability. H.R.6, "The 21st Century Cures Act" and Senate companions, ensuring no new barriers to generic and biosimilar market entry. Generic Drug User Fee Act Reauthorization, support increasing generic availability. H.R.1600, "The Patients' Access to Treatment Act," educating on the importance of step therapy to ensuring optimal therapy access and cost control. S.480/H.R.1725, "National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015," educating on the importance of PDMPs and the need for federal funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.